Together, these results suggest that, although CPZ selectively targets AML cells with MT-RTKs mainly through CALM protein depletion, its activities to inhibit other molecules such as DR and 5-HTR might partially contribute to full anti-AML activities of CPZ depending on cellular contexts. This evidence concerns the gene PICALM and acute myeloid leukemia.